0001646343-19-000007.txt : 20190814
0001646343-19-000007.hdr.sgml : 20190814
20190814160859
ACCESSION NUMBER: 0001646343-19-000007
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190630
FILED AS OF DATE: 20190814
DATE AS OF CHANGE: 20190814
EFFECTIVENESS DATE: 20190814
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEXTHERA CAPITAL LP
CENTRAL INDEX KEY: 0001646343
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-17280
FILM NUMBER: 191026394
BUSINESS ADDRESS:
STREET 1: 900 THIRD AVENUE
STREET 2: SUITE 201-2
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 213-7033
MAIL ADDRESS:
STREET 1: 900 THIRD AVENUE
STREET 2: SUITE 201-2
CITY: NEW YORK
STATE: NY
ZIP: 10022
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001646343
XXXXXXXX
06-30-2019
06-30-2019
NEXTHERA CAPITAL LP
900 THIRD AVENUE
SUITE 201-2
NEW YORK
NY
10022
13F HOLDINGS REPORT
028-17280
N
Daniel Malek
Managing Member/CEO
6462137030
Daniel Malek
New York
NY
08-14-2019
0
23
120064
false
INFORMATION TABLE
2
nexthera13f_q22019.xml
AbbVie Inc
COM
00287Y109
3831
52681
SH
SOLE
52681
0
0
Allergan PLC
SHS
G0177J108
560
3347
SH
SOLE
3347
0
0
Amarin Corp PLC
SPONS ADR NEW
023111206
4465
230295
SH
SOLE
230295
0
0
AnaptysBio Inc
COM
032724106
679
12026
SH
SOLE
12026
0
0
Ascendis Pharma A/S
SPONSORED ADR
04351P101
6940
60266
SH
SOLE
60266
0
0
Biohaven Pharmaceutical Holdin
COM
G11196105
3773
86165
SH
SOLE
86165
0
0
Audentes Therapeutics Inc
COM
05070R104
11131
294013
SH
SOLE
294013
0
0
Coherus Biosciences Inc
COM
19249H103
6991
316316
SH
SOLE
316316
0
0
Dermira Inc
COM
24983L104
1320
138102
SH
SOLE
138102
0
0
Global Blood Therapeutics Inc
COM
37890U108
7485
142305
SH
SOLE
142305
0
0
Gilead Sciences Inc
COM
375558103
1263
18697
SH
SOLE
18697
0
0
Intercept Pharmaceuticals Inc
COM
45845P108
12130
152441
SH
SOLE
152441
0
0
Immunomedics Inc
COM
452907108
7270
524140
SH
SOLE
524140
0
0
Insmed Inc
COM PAR $.01
457669307
12051
470741
SH
SOLE
470741
0
0
Intra-Cellular Therapies Inc
COM
46116X101
1865
143665
SH
SOLE
143665
0
0
Madrigal Pharmaceuticals Inc
COM
558868105
1616
15423
SH
SOLE
15423
0
0
Mylan NV
SHS EURO
N59465109
1953
102560
SH
SOLE
102560
0
0
Neurocrine Biosciences Inc
COM
64125C109
7800
92380
SH
SOLE
92380
0
0
Pacira BioSciences Inc
COM
695127100
6484
149086
SH
SOLE
149086
0
0
uniQure NV
SHS
N90064101
4680
59883
SH
SOLE
59883
0
0
Regeneron Pharmaceuticals Inc
COM
75886F107
1774
5668
SH
SOLE
5668
0
0
Sarepta Therapeutics Inc
COM
803607100
7646
50317
SH
SOLE
50317
0
0
UroGen Pharma Ltd
COM
M96088105
6357
176866
SH
SOLE
176866
0
0